XHE:NYE-SPDR® S&P Health Care Equipment ETF (USD)

ETF | Health |

Last Closing

USD 88.16

Change

-0.33 (-0.37)%

Market Cap

USD 0.22B

Volume

3.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.31 (-0.20%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

-0.08 (-0.11%)

USD 2.97B
FXH First Trust Health Care AlphaD..

-0.78 (-0.71%)

USD 1.29B
IDNA iShares Genomics Immunology an..

+0.03 (+0.12%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.02 (+0.06%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

-0.11 (-0.12%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.02 (-0.06%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

+0.70 (+1.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.05 (+0.18%)

USD 0.01B
IHE iShares U.S. Pharmaceuticals E..

-0.15 (-0.21%)

N/A

ETFs Containing XHE

INAV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.63% 10% F 40% F
Dividend Return 0.01% 6% D- 1% F
Total Return 4.64% 10% F 30% F
Trailing 12 Months  
Capital Gain 16.44% 24% F 45% F
Dividend Return 0.05% 6% D- 1% F
Total Return 16.49% 19% F 39% F
Trailing 5 Years  
Capital Gain 15.23% 10% F 52% F
Dividend Return 0.06% 6% D- 1% F
Total Return 15.29% 10% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 1.99% N/A N/A 45% F
Dividend Return 2.00% N/A N/A 35% F
Total Return 0.01% N/A N/A 1% F
Risk Return Profile  
Volatility (Standard Deviation) 26.43% N/A N/A 39% F
Risk Adjusted Return 7.55% N/A N/A 29% F
Market Capitalization 0.22B 70% C- 37% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.